Close Menu

NEW YORK (GenomeWeb) – Genomic Health announced today that national Medicare contractor Palmetto GBA has issued a favorable final local coverage determination expanding coverage of the company's Oncotype DX prostate cancer test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.